Robyn Leary

For all people undergoing chemotherapy who want to keep their identity, Cooler Heads is transforming cold cap therapy. We are making cold caps affordable, easy to use, and effective so all solid tumor patients facing hair loss from chemotherapy can choose to keep their hair.

Pismo Ventures is a unique venture capital firm that invests in early-stage scalable startups at the stages of pre-seed, seed and series A. We are industry agnostic, have a large investor network, and syndicate with other investment groups. Our advisory arm provides proven business strategies and helps raise capital for startups with great teams and domain expertise. We strive to assist startups in decreasing the risk of failure and increasing the likelihood of success.

For all people undergoing chemotherapy who want to keep their identity, Cooler Heads is transforming cold cap therapy. We are making cold caps affordable, easy to use, and effective so all solid tumor patients facing hair loss from chemotherapy can choose to keep their hair.

Founded in San Diego, CA, NuFund is one of the largest, most active and most successful early-stage investor groups over the past 20+ years. We represent diverse backgrounds and perspectives, and work together to foster a culture of excellence, respect, innovation, and fun.

WERE ALL IN FOR FIGHT AGAINST CANCER Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients. We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes. THE PATIENT IS NUMBER ONE We believe that being a cancer company begins and ends with the patient. We strive to support patient needs throughout their treatment journey to help them make the treatment choices that are right for them and their loved ones. FIGHTING CANCER IS TEAM SPORT We believe that cancer is a complex, dynamic disease that requires a multi-faceted, multi-disciplinary approach to tackle. We believe in teamwork at each stage of a therapy’s development, and seek to build teams of experts, both internally and externally, that cover the breadth and depth of the complex problem that is cancer. We work with leading companies and investigators to ensure that our products are tested in the best settings, and in combination with highest potential regimens to maximize benefit to patients and to advance the understanding of cancer treatment. We seek to engage all members of the cancer treatment team as well as thought-leading physicians and patient advocacy organizations to ensure that clear, complete and balanced information about our products is proactively communicated and readily available. We work to support the extraordinary dedication of the medical teams that represent the front lines in the war on cancer. OUTCOMES ARE OUR YARDSTICK We believe that innovation is not enough. In the challenging world of today’s healthcare climate, we strive to develop and assess our products based on the real-world impact they have in improving the quality and duration of our patients’ lives. We measure our success in the birthdays, anniversaries and other important life moments that our patients are able to enjoy.

Scripps Research is a leader in the discovery and application of biomedical breakthroughs that improve human health. As the worlds largest independent non-profit biomedical research facility, we expand the frontiers of science and education and create hope for millions. Scripps Research is ranked #1 for innovation by the Nature Index.